SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022100
Filing Date
2022-08-11
Accepted
2022-08-11 16:25:56
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 881097
2 ex10-1.htm EX-10.1 329527
3 ex31-1.htm EX-31.1 12029
4 ex31-2.htm EX-31.2 12541
5 ex32-1.htm EX-32.1 8855
  Complete submission text file 0001493152-22-022100.txt   5241737

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eton-20220630.xsd EX-101.SCH 38605
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eton-20220630_cal.xml EX-101.CAL 47071
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eton-20220630_def.xml EX-101.DEF 196557
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eton-20220630_lab.xml EX-101.LAB 357538
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eton-20220630_pre.xml EX-101.PRE 273760
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 615128
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 221156263
SIC: 2834 Pharmaceutical Preparations